Argenx Se (ARGX) Income towards Parent Company (2016 - 2026)

Argenx Se (ARGX) posted quarterly Income towards Parent Company of $472.0 million for Q2 2026, up 92.37% year-on-year from $245.4 million in Q2 2025, and up 28.96% on a QoQ basis from $366.0 million in Q1 2026.

Argenx Se (ARGX) Income towards Parent Company (2016 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Income towards Parent Company for 11 consecutive years, with $472.0 million the latest figure, recorded in Q2 2026.

  • Quarterly Income towards Parent Company rose 92.37% year-over-year to $472.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.7 billion (up 34.01% YoY) and the FY2025 annual result came in at $1.3 billion, up 55.1% from the prior year.
  • Income towards Parent Company rose to $472.0 million in Q2 2026 per ARGX's latest filing, from $366.0 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for ARGX reached as high as $774.2 million in Q4 2024 and fell as low as -$227.2 million in Q1 2022.
  • A 5-year average of $186.5 million and a median of $130.2 million in 2024 frame the typical range for Income towards Parent Company.
  • The largest YoY upside for Income towards Parent Company was 2816.87% in 2022 against a maximum downside of 661.88% in 2022.
  • Year by year, Income towards Parent Company stood at -$38.6 million in 2022, then sank by 156.84% to -$99.2 million in 2023, then soared by 880.62% to $774.2 million in 2024, then slumped by 31.16% to $532.9 million in 2025, then retreated by 11.44% to $472.0 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered $472.0 million, $366.0 million, and $532.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Alnylam Pharmaceuticals 37.29 Bn 34.28 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 472.00 Mn
Mar 31, 2026 366.00 Mn
Dec 31, 2025 532.95 Mn
Sep 30, 2025 344.26 Mn
Jun 30, 2025 245.36 Mn
Mar 31, 2025 169.00 Mn
Dec 31, 2024 774.16 Mn
Sep 30, 2024 91.41 Mn
Jun 30, 2024 29.07 Mn
Mar 31, 2024 -61.60 Mn
Dec 31, 2023 -99.17 Mn
Sep 30, 2023 -72.64 Mn
Jun 30, 2023 -94.37 Mn
Mar 31, 2023 28.87 Mn
Dec 31, 2022 -38.61 Mn
Sep 30, 2022 235.04 Mn
Jun 30, 2022 663.12 Mn
Mar 31, 2022 -227.19 Mn
Dec 31, 2021 -237.82 Mn
Sep 30, 2021 -233.61 Mn